Michael Newton


Michael is an Associate in the Life Sciences and Chemistry group specialising in biotechnology, therapeutics and diagnostics. He has particular expertise in the fields of antibody technology, cell culture, cell therapy, bioinformatics, computational biology, genomic medicine and synthetic biology.
His clients include SMEs, overseas law firms, universities and multinationals. Michael has experience of drafting new patent applications and prosecutes UK and European patent applications. He also coordinates international prosecution of complex patent portfolios, which involves working with local attorneys in countries such as Australia, China, Japan, Korea and the US. In addition, Michael is regularly involved in post-grant opposition procedures before the European Patent Office.
Michael completed his PhD studies under Prof. Alun Davies FRS, focusing on the expression and signalling of the extracellular calcium sensing receptor (CaSR) in the developing murine nervous system. As a member of a Wellcome Trust funded four-year Neuroscience PhD programme, Michael also cultivated an interest in diverse areas of research, including behavioural neuroscience and medical genetics. Michael graduated with a First Class degree in Biochemistry from Southampton University, where he was awarded the 'Biochemistry Prize' for best aggregate performance.
Michael prides himself on providing pragmatic, commercially-minded advice, tailoring his guidance to suit each client.


European Patent Attorney
Chartered UK Patent Attorney
Certificate in Intellectual Property Law – Queen Mary University (2015)
PhD Integrative Neuroscience – Cardiff University (2013)
BSc (Hons) Biochemistry – University of Southampton (2008)


Chartered Institute of Patent Attorneys (CIPA)
The Institute of Professional Representatives before the European Patent Office (EPI)

Selected Publications

​M. Newton, AI and Drug Discovery, Kilburn & Strode, (2020)

​M. Newton, AI Diagnostics and Digital Healthcare, Kilburn & Strode, (2020)

​M. Newton, AI in Drug Repurposing, Kilburn & Strode, (2020)

M. Newton, Patent eligibility of cultured cells in the US: A European perspective, Kilburn & Strode, (2019)

Newton M. Differences in Culture: Expanded Cells Held Patent Eligible in the US. European Intellectual Property Review (2019) 41(2), 123-126

Newton M. Don't treat a subject; treat a disease, Kilburn & Strode (2018)

Vizard TN*, Newton M*, Howard L, Wyatt S, Davies AM. ERK signaling mediates CaSR-promoted axon growth. Neuroscience Letters (2015) 603:77–83. 
* These authors contributed equally to this work.

Albasser MM, Olarte-Sánchez CM, Amin E, Horne MR, Newton MJ, Warburton EC, Aggleton JP. The neural basis of nonvisual object recognition memory in the rat. Behavioral Neuroscience (2013) 127(1):70-85.

Hands S, Sajjad MU, Newton MJ, Wyttenbach A. In vitro and in vivo aggregation of a fragment of huntingtin protein directly causes free radical production. Journal of Biological Chemistry (2011) 286(52):44512-20.

Newton M, Niewczas I, Clark J, Bellamy TC. A real-time fluorescent assay of the purified nitric oxide receptor, guanylyl cyclase. Analytical Biochemistry (2010) 402(2):129-36.

  • Biotechnology
  • Medical Devices
  • Biologics
  • Healthcare
  • Patents

The life sciences and chemistry team regularly writes about trends, developments and legal updates in the IP industry in our News & insights hub.

Read here

Cookies improve the way our website works. By using this website you are agreeing to our use of cookies. For more information see our cookie policy I accept